FDA grants EUA to BD's SARS-CoV-2/Flu assay
FDA grants EUA to BD's SARS-CoV-2/Flu assay FDA grants EUA to BD's SARS-CoV-2/Flu assay 15 February 2021 | News The BD® SARS-CoV-2/Flu assay is run on the BD MAX™ System and distinguishes between SARS-CoV-2 and Influenza A+B, providing a positive or negative result for each virus using a single specimen Source: PR Newswire BD (Becton, Dickinson and Company), a leading global medical technology company, has announced that the US Food and Drug Administration (FDA) has granted Emergency Use Authorisation (EUA) for a new molecular diagnostic test for both SARS-CoV-2 and Influenza A+B...
Source: biospectrumindia.com